Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Uday RS Namburi
Clinical Efficacy and Safety of “Vasavaleha” in the Management of Stable Chronic Bronchitis: A Prospective Open Label Multicenter Study
Journal of Research in Ayurvedic Sciences
Related publications
Efficacy and Safety of Moxifloxacin in Acute Exacerbations of Chronic Bronchitis: A Prospective, Multicenter, Observational Study (AVANTI)
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Efficacy and Safety of Privigen®in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-Arm, Open-Label Phase III Study (The PRIMA Study)
Journal of the Peripheral Nervous System
Medicine
Neuroscience
Neurology
A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain
Current Oncology
Oncology
Efficacy and Safety of Octanorm (Cutaquig®) in Adults With Primary Immunodeficiencies With Predominant Antibody Deficiency: A Prospective, Open-Label Study
Immunotherapy
Oncology
Allergy
Immunology
An Open Label, Multicenter, Non-Comparative Study of the Efficacy and Safety of Oral Gatifloxacin in the Treatment of Community-Acquired Pneumonia: A Brazilian Study in Five Centers
Brazilian Journal of Infectious Diseases
Infectious Diseases
Microbiology
A Multicenter, Open Label, Uncontrolled, Phase Ii Trial Evaluating Safety and Efficacy of Venetoclax, Atezolizumab Andobinutuzumab in Richter Transformation From CLL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients With Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Registration Directed Phase 2 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Efficacy and Tolerability of Carbamazepine for the Treatment of Painful Diabetic Neuropathy in Adults: A 12-Week, Open-Label, Multicenter Study
International Journal of General Medicine
Medicine
The Maraviroc Expanded Access Program — Safety and Efficacy Data From an Open-Label Study
HIV Clinical Trials
